The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-631x|5|1|54-68

ISSN： 1573-3955

Source： Current Immunology Reviews, Vol.5, Iss.1, 2009-02, pp. : 54-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble CTLA-4 in Sera of Patients with Bronchial Asthma

By Shi Huan-Zhong   Mo Xiao-Yun   Zhong Xiao-Ning  

Journal of Asthma, Vol. 42, Iss. 2, 2004-03 ,pp. : 133-139

Informa Healthcare

Access to resources Recommend Favorite

CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy

By Young-Min Steven   Vaidya Bijay  

Clinical Rheumatology, Vol. 23, Iss. 6, 2004-12 ,pp. : 568-569

Springer Publishing Company

Access to resources Recommend Favorite

The dual role of CTLA-4 in Leishmania infection

By Gomes N.A.   DosReis G.A.  

Trends in Parasitology, Vol. 17, Iss. 10, 2001-10 ,pp. : 487-491

Elsevier

Access to resources Recommend Favorite

Emerging Role of Complement in Ocular Diseases

By  

Current Immunology Reviews, Vol. 7, Iss. 3, 2011-08 ,pp. : 360-367

Bentham Science Publishers

Access to resources Recommend Favorite

The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases

By Soares João-Bruno  

Hepatology International, Vol. 4, Iss. 4, 2010-12 ,pp. : 659-672

Springer Publishing Company

Access to resources Recommend Favorite